431 related articles for article (PubMed ID: 9842449)
1. Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans.
Friedrich F
Acta Virol; 1998 Jun; 42(3):187-94. PubMed ID: 9842449
[TBL] [Abstract][Full Text] [Related]
2. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
Friedrich F
Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
[TBL] [Abstract][Full Text] [Related]
3. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
Friedrich F
Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
[TBL] [Abstract][Full Text] [Related]
4. Use of mutational pattern in 5'-NCR and VP1 regions of polioviruses for molecular diagnosis.
Pliaka V; Dedepsidis E; Kyriakopoulou Z; Papadopoulou I; Levidiotou S; Markoulatos P
Mol Cell Probes; 2007 Aug; 21(4):267-75. PubMed ID: 17336496
[TBL] [Abstract][Full Text] [Related]
5. Three cases of paralytic poliomyelitis associated with type 3 vaccine poliovirus strains in Bulgaria.
Korsun N; Kojouharova M; Vladimirova N; Fiore L; Litvinenko I; Buttinelli G; Fiore S; Voynova-Georgieva V; Mladenova Z; Georgieva D
J Med Virol; 2009 Sep; 81(9):1661-7. PubMed ID: 19626606
[TBL] [Abstract][Full Text] [Related]
6. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H
J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
[TBL] [Abstract][Full Text] [Related]
8. Rare adverse events associated with oral poliovirus vaccine in Brazil.
Friedrich F
Braz J Med Biol Res; 1997 Jun; 30(6):695-703. PubMed ID: 9292105
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
[TBL] [Abstract][Full Text] [Related]
10. Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.
Rahimi P; Tabatabaie H; Gouya MM; Zahraie M; Mahmudi M; Ziaie A; Rad KS; Shahmahmudi Sh; Musavi T; Azad TM; Nategh R
J Clin Virol; 2007 Aug; 39(4):304-7. PubMed ID: 17590391
[TBL] [Abstract][Full Text] [Related]
11. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
Pliaka V; Kyriakopoulou Z; Markoulatos P
Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
[TBL] [Abstract][Full Text] [Related]
12. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
Friedrich F; Da-Silva EF; Schatzmayr HG
Acta Virol; 1996 Feb; 40(1):27-33. PubMed ID: 8886095
[TBL] [Abstract][Full Text] [Related]
13. High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis.
Georgescu MM; Delpeyroux F; Tardy-Panit M; Balanant J; Combiescu M; Combiescu AA; Guillot S; Crainic R
J Virol; 1994 Dec; 68(12):8089-101. PubMed ID: 7966599
[TBL] [Abstract][Full Text] [Related]
14. Retrospective molecular and phenotypic analysis of poliovirus vaccine strains isolated in Greece.
Pliaka V; Filliponi ME; Kyriakopoulou Z; Ruether IG; Tsakogiannis D; Gartzonika C; Levidiotou-Stefanou S; Markoulatos P
Clin Microbiol Infect; 2011 Oct; 17(10):1554-62. PubMed ID: 21375661
[TBL] [Abstract][Full Text] [Related]
15. Poliomyelitis in Russia in 1998-1999.
Ivanova OE; Eremeeva TP; Karganova GG; Rumyantsev AA; Leshinskaya EV; Lipskaya GY; Cherkasova EA; Korotkova EA; Grachev VP; Drozdov SG
Dev Biol (Basel); 2001; 105():219-23. PubMed ID: 11763331
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary.
Kapusinszky B; Molnár Z; Szomor KN; Berencsi G
FEMS Immunol Med Microbiol; 2010 Mar; 58(2):211-7. PubMed ID: 19863665
[TBL] [Abstract][Full Text] [Related]
17. [Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].
Delpeyroux F; Guillot S; Szendröi A; Balanant J; Caro V; Cuervo N; Chevaliez S; Dahourou G; Crainic R
Bull Soc Pathol Exot; 2000 Jul; 93(3):193-7. PubMed ID: 11030056
[TBL] [Abstract][Full Text] [Related]
18. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
[TBL] [Abstract][Full Text] [Related]
19. Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses.
Otelea D; Guillot S; Furione M; Combiescu AA; Balanant J; Candrea A; Crainic R
Dev Biol Stand; 1993; 78():33-8. PubMed ID: 8099049
[TBL] [Abstract][Full Text] [Related]
20. A developing country perspective on vaccine-associated paralytic poliomyelitis.
John TJ
Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
